PolyPid (PYPD) Current Assets (2019 - 2026)
PolyPid (PYPD) posted Current Assets of $12.6 million for Q1 2026, down 17.51% sequentially from $15.2 million in Q4 2025, and up 43.18% YoY from $8.8 million in Q1 2025.
PolyPid (PYPD) Current Assets (2019 - 2026) Analysis & Trends
PolyPid has reported Current Assets for 8 years, with the latest figure at $12.6 million in Q1 2026.
- Quarterly Current Assets rose 43.18% year-over-year to $12.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.6 million (up 43.18% YoY) and the FY2025 annual result came in at $15.2 million, down 8.12% from the prior year.
- Current Assets declined to $12.6 million in Q1 2026 per PYPD's latest filing, from $15.2 million in the prior quarter.
- Over five years, Current Assets peaked at $30.0 million in Q2 2025 and troughed at $6.1 million in Q4 2023.
- A 5-year average of $16.2 million and a median of $15.2 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets sank 59.23% in 2022, then jumped 206.69% in 2025.
- Over 5 years, Current Assets stood at $14.2 million in 2022, then slumped by 57.26% to $6.1 million in 2023, then surged by 173.17% to $16.6 million in 2024, then dropped by 8.12% to $15.2 million in 2025, then retreated by 17.51% to $12.6 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $12.6 million, $15.2 million, and $19.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | PolyPid | 113.30 Mn | 106.53 Mn | - | 8.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.89 Mn |
| Mar 31, 2026 | 12.56 Mn |
| Dec 31, 2025 | 15.23 Mn |
| Sep 30, 2025 | 19.58 Mn |
| Jun 30, 2025 | 29.99 Mn |
| Mar 31, 2025 | 8.77 Mn |
| Dec 31, 2024 | 16.57 Mn |
| Sep 30, 2024 | 10.45 Mn |
| Jun 30, 2024 | 9.78 Mn |
| Mar 31, 2024 | 15.09 Mn |
| Dec 31, 2023 | 6.07 Mn |
| Sep 30, 2023 | 11.12 Mn |
| Jun 30, 2023 | 15.75 Mn |
| Mar 31, 2023 | 20.59 Mn |
| Dec 31, 2022 | 14.19 Mn |
| Sep 30, 2022 | 19.80 Mn |
| Jun 30, 2022 | 25.02 Mn |
| Mar 31, 2022 | 25.49 Mn |
| Dec 31, 2021 | 34.81 Mn |
| Sep 30, 2021 | 45.32 Mn |